New Frontiers in 3D | Visionaries Speak
51 FOLLOWERS
Join us for a virtual fireside chat with visionaries in biopharma! We're
bringing together biopharma key option leaders recognized for their
contributions to innovative human disease research and translational
safety to share their thoughts on technologies that are transforming
drug discovery.
New Frontiers in 3D | Visionaries Speak
2y ago
Our Panelists
Dr. Terry Riss, Senior Product Manager, Cell Health, Promega Corporation
Dr. Terry Riss started the Cell Biology program at Promega Corporation in 1990. He managed the development of cell viability, cytotoxicity, apoptosis, and protease assay systems and lead efforts to identify and promote multiplexing of cell-based assays to determine the mechanism of cell death. He now serves as Senior Product Manager, Cell Health, involved in outreach educational training activities, including validating assay systems applied to 3D cell culture models. Terry is also an editor of the In Vitro ..read more
New Frontiers in 3D | Visionaries Speak
3y ago
Our Panelists
Prof. Matthias Hebrok, Professor at the Diabetes Center at the University of California San Francisco
Matthias Hebrok is Hurlbut-Johnson Distinguished Professor in Diabetes Research at the Diabetes Center at the University of California San Francisco. He received his Diploma degree in Cell Biology from the Albert-Ludwigs University, performed his PhD thesis at the Max-Planck-Institute, and conducted his postdoctoral research at HHMI at Harvard University. His laboratory has made seminal contributions to our understanding of how embryonic signals control the fetal development of t ..read more
New Frontiers in 3D | Visionaries Speak
3y ago
Our Panelists Academic Perspective
Prof. Jaap den Toonder, Professor and Chair of the Microsystems section, Eindhoven University of Technology
Jaap is a full professor and Chair of the Microsystems section at Eindhoven University of Technology, and former Principal Scientist and Chief Technologist at Philips Research. He received his PhD in Mechanical Engineering from Delft University of Technology. His research focuses on the investigation and development of novel microsystems design approaches and out-of-cleanroom fabrication technologies. His application focus is on microfluidic chips, biom ..read more
New Frontiers in 3D | Visionaries Speak
3y ago
This episode aired originally live at https://newfrontiersin3d.com/
In this podcast we address key questions, such as:
Do animals predict human drug safety correctly? What are the general limitations?
How can we increase predictivity of drug safety for patients?
What are the challenges for evaluating new therapeutic modalities?
What are the most promising new animal-free technologies and testing strategies for risk assessment?
What will drug safety risk assessment look like in 2030?
Our Speakers
Pharmaceutical Industry Perspective
Dr. Stefan Platz, Senior Vice President and Head of Clinical ..read more